STERIS Management
Management criteria checks 4/4
STERIS' CEO is Dan Carestio, appointed in Jul 2021, has a tenure of 2.75 years. total yearly compensation is $7.74M, comprised of 12.5% salary and 87.5% bonuses, including company stock and options. directly owns 0.048% of the company’s shares, worth $9.68M. The average tenure of the management team and the board of directors is 4.2 years and 7.2 years respectively.
Key information
Dan Carestio
Chief executive officer
US$7.7m
Total compensation
| CEO salary percentage | 12.5% |
| CEO tenure | 2.8yrs |
| CEO ownership | 0.05% |
| Management average tenure | 4.2yrs |
| Board average tenure | 7.2yrs |
Recent management updates
Recent updates
Steris: Moving On, Losing Its Teeth
Apr 14STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 31% Above Its Share Price
Mar 29
STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet
Mar 07Steris: Strong Healthcare Products Growth Coupled With Weak AST Business
Feb 17STERIS plc's (NYSE:STE) Business Is Trailing The Industry But Its Shares Aren't
Feb 15An Intrinsic Calculation For STERIS plc (NYSE:STE) Suggests It's 23% Undervalued
Dec 17Should You Investigate STERIS plc (NYSE:STE) At US$203?
Nov 24Steris: Comprehensive Sterilization Portfolios Tailored To Procedure Volumes
Nov 08We Think STERIS (NYSE:STE) Can Stay On Top Of Its Debt
Nov 06Are STERIS plc (NYSE:STE) Investors Paying Above The Intrinsic Value?
Sep 18Steris: Remains On Track For Strong Fiscal '24, Added Upsides From Operating Leverage
Sep 01When Should You Buy STERIS plc (NYSE:STE)?
Aug 10Steris: Continuing To Grow The Product Lineup
Jun 20Steris falls 10% on Q3 revenue, profit miss, 2023 profit guidance lowered
Feb 09Steris declares $0.47 dividend
Feb 01These 4 Measures Indicate That STERIS (NYSE:STE) Is Using Debt Reasonably Well
Feb 01Calculating The Intrinsic Value Of STERIS plc (NYSE:STE)
Dec 28Steris declares $0.47 dividend
Nov 02STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly
Nov 01Steris: Non-GAAP Valuations Supportive Of Substantial Upside
Sep 04STERIS (NYSE:STE) Will Pay A Larger Dividend Than Last Year At $0.47
Aug 18STERIS' (NYSE:STE) Dividend Will Be Increased To $0.47
Aug 04Steris Non-GAAP EPS of $1.90 in-line, revenue of $1.2B misses by $20M
Aug 02Is STERIS (NYSE:STE) A Risky Investment?
Jul 19Steris: Deleveraging Key Undercurrent, Valuation A Concern
Jun 12STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly
Apr 08Steris: Another Essential Healthcare Supply Resource
Feb 01Is STERIS (NYSE:STE) A Risky Investment?
Dec 15STERIS (NYSE:STE) Is Increasing Its Dividend To US$0.43
Nov 01CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | US$567m |
| Sep 30 2023 | n/a | n/a | US$550m |
| Jun 30 2023 | n/a | n/a | US$119m |
| Mar 31 2023 | US$8m | US$970k | US$107m |
| Dec 31 2022 | n/a | n/a | -US$28m |
| Sep 30 2022 | n/a | n/a | -US$8m |
| Jun 30 2022 | n/a | n/a | US$377m |
| Mar 31 2022 | US$6m | US$767k | US$244m |
| Dec 31 2021 | n/a | n/a | US$279m |
| Sep 30 2021 | n/a | n/a | US$250m |
| Jun 30 2021 | n/a | n/a | US$286m |
| Mar 31 2021 | US$3m | US$542k | US$397m |
| Dec 31 2020 | n/a | n/a | US$433m |
| Sep 30 2020 | n/a | n/a | US$424m |
| Jun 30 2020 | n/a | n/a | US$413m |
| Mar 31 2020 | US$2m | US$522k | US$408m |
| Dec 31 2019 | n/a | n/a | US$393m |
| Sep 30 2019 | n/a | n/a | US$336m |
| Jun 30 2019 | n/a | n/a | US$319m |
| Mar 31 2019 | US$2m | US$482k | US$304m |
| Dec 31 2018 | n/a | n/a | US$269m |
| Sep 30 2018 | n/a | n/a | US$316m |
| Jun 30 2018 | n/a | n/a | US$303m |
| Mar 31 2018 | US$1m | US$379k | US$291m |
Compensation vs Market: Dan's total compensation ($USD7.74M) is below average for companies of similar size in the US market ($USD13.51M).
Compensation vs Earnings: Dan's compensation has been consistent with company performance over the past year.
CEO
Dan Carestio (50 yo)
2.8yrs
Tenure
US$7,740,184
Compensation
Mr. Daniel A. Carestio, also known as Dan, serves as the Chief Executive Officer & President at STERIS plc since July 29, 2021. He had been Senior Vice President and Chief Operating Officer at STERIS plc s...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.8yrs | US$7.74m | 0.048% $ 9.7m | |
| Senior VP & CFO | 16.1yrs | US$2.89m | 0.047% $ 9.5m | |
| Senior VP | 10.8yrs | US$2.26m | 0.031% $ 6.2m | |
| SVP & Chief Human Resources Officer | 3.8yrs | US$1.48m | 0.0094% $ 1.9m | |
| Senior Vice President & President of Healthcare | 4.7yrs | US$1.59m | 0.014% $ 2.8m | |
| Chief Accounting Officer | 15.9yrs | no data | 0.0068% $ 1.4m | |
| Vice President of Investor Relations & Corporate Communications | no data | no data | no data | |
| Senior Vice President of Life Sciences | 3.8yrs | no data | 0.0086% $ 1.8m | |
| Senior VP & GM of Dental | 2.8yrs | US$1.92m | 0.0066% $ 1.3m | |
| Senior VP & GM of AST | no data | no data | 0.0022% $ 455.9k | |
| VP & Corporate Treasurer | 6.7yrs | no data | 0.0068% $ 1.4m | |
| CEO Emeritus & Senior Advisor | 2.8yrs | US$1.16m | no data |
4.2yrs
Average Tenure
54.5yo
Average Age
Experienced Management: STE's management team is considered experienced (4.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.3yrs | US$7.74m | 0.048% $ 9.7m | |
| Independent Director | 16yrs | US$345.80k | 0.028% $ 5.8m | |
| Independent Chairman of the Board | 18.8yrs | US$464.87k | 0.023% $ 4.6m | |
| Independent Director | 20.5yrs | US$340.81k | 0.027% $ 5.5m | |
| Independent Director | 19.1yrs | US$341.82k | 0.0095% $ 1.9m | |
| Independent Director | 8.4yrs | US$341.81k | 0% $ 0 | |
| Independent Director | 2.9yrs | US$328.34k | no data | |
| Independent Director | 5.9yrs | US$328.30k | 0.00030% $ 61.1k | |
| Independent Director | 3.8yrs | US$334.34k | 0.000070% $ 14.2k | |
| Independent Director | less than a year | no data | no data |
7.2yrs
Average Tenure
64.5yo
Average Age
Experienced Board: STE's board of directors are considered experienced (7.2 years average tenure).